The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Mutations of EGFR, K-ras, and EML-4ALK genes in resected lung adenocarcinoma and their clinical significance.
T. Ohba
No relevant relationships to disclose
K. Sugio
No relevant relationships to disclose
T. Kometani
No relevant relationships to disclose
M. Yamaguchi
No relevant relationships to disclose
M. Hamatake
No relevant relationships to disclose
K. Nosaki
No relevant relationships to disclose
H. Takeoka
No relevant relationships to disclose
H. Kitajima
No relevant relationships to disclose
F. Hirai
No relevant relationships to disclose
T. Seto
No relevant relationships to disclose
Y. Ichinose
No relevant relationships to disclose